Objective-Cholesterol 7␣-hydroxylase (cyp7a1) catalyzes the rate-limiting step in conversion of cholesterol to bile acids.
T he liver plays a central role in the regulation and maintenance of the whole-body sterol balance. The conversion of cholesterol into bile acids and their subsequent fecal excretion is quantitatively the most important way for elimination of cholesterol from the body. In the intestine, bile acids are important as physiological detergents that facilitate the absorption of lipid-soluble vitamins and dietary fat. The classical or neutral route in bile acid biosynthesis is initiated by 7␣-hydroxylation of cholesterol catalyzed by the major rate-limiting enzyme cholesterol 7␣-hydroxylase (cyp7a1), which is located in the smooth endoplasmic reticulum. 1, 2 The rate of bile acid biosynthesis is under control of different molecular mechanisms in which nuclear receptors are involved. In most species, except for humans, the liver X receptor ␣ (LXR␣) is involved in the feed-forward regulation of cyp7a1 by cholesterol, whereas the feedback regulation by bile acids is mediated via the farnesoid X-receptor (FXR). 3 Several studies have shown coordinate regulation between cholesterol 7␣-hydroxylase and the assembly and secretion of apolipoprotein B-containing lipoproteins in humans 4, 5 and in animal models. 6, 7 Patients treated with bile acid sequestrants, in which cyp7a1 expression is increased, have hypertriglyceridemia as a consequence of an induction in hepatic very-low-density lipoprotein (VLDL) secretion. 8 -10 In line with these studies, mice overexpressing cyp7a1 have increased VLDL production. 6 These studies suggest a link between degradation of cholesterol into bile acids and hepatic VLDL production.
To further study the relationship between bile acid biosynthesis and triglyceride metabolism, we cross-bred mice lacking cyp7a1 11 on a hyperlipidemic APOE*3-Leiden background, thereby increasing the sensitivity of the effect of removal of cyp7a1 on lipoprotein and lipid metabolism. Because of the concomitant expression of APOE*3-Leiden and APOC1, these mice have a defective clearance of apolipoprotein B-containing lipoproteins and therefore show a more human-like lipoprotein profile. 12 Our data show that female cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice have a decreased VLDL production as a consequence of a strongly reduced bile acid biosynthesis, leading to reduced plasma triglyceride levels. These data reveal a major effect of physiological cyp7a1 expression on VLDL production and further underscore the link between bile acid biosynthesis and triglyceride levels.
Methods

Animals
Cyp7a1 Ϫ/Ϫ mice 11 were obtained from Jackson Laboratory (Bar Harbor, Me) and cross-bred on an APOE*3-Leiden background 12 (line 2, Ͼ99% C57Bl/6). Specifically, male cyp7a1 ϩ/Ϫ .APOE*3-Leiden mice were crossed with female cyp7a1 ϩ/Ϫ mice to generate cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice and APOE*3-Leiden littermate controls. Pregnant females were administered additional vitamins throughout the nursing period. All experiments were performed with 16-to 22-week-old female mice, which were maintained on a reversed 12-hour dark and 12-hour light cycle and allowed free access to food and water. Body weight of the mice and the consumption of diet and water were recorded weekly and did not differ between cyp7a1 Ϫ/Ϫ .APOE*3-Leiden and APOE*3-Leiden mice during the whole experimental period. In some experiments (indicated in text or legends), mice were fed a sucrose-rich diet (Hope Farms, Woerden, The Netherlands) 13 for 3 weeks. Institutional guidelines for animal care were observed in all experiments.
Analysis of Blood Parameters
After overnight fasting, blood samples were collected into paraoxonase-coated capillaries 14 after tail incision. Plasma total cholesterol, triglycerides (corrected for plasma levels of free glycerol), and plasma ␤-hydroxybutyrate (as a measure of in vivo ␤-oxidation) were measured enzymatically (CHOD-PAP method, Roche, 236691, GPO-trinder, Sigma, 337-B, and Sigma Diagnostics, 310-A, respectively).
Hepatic RNA Isolation and Measurement of mRNA Levels by Real-Time Polymerase Chain Reaction
Total RNA was isolated from liver tissue as described previously. 15 RNA was converted to single-stranded cDNA by a reverse-transcription procedure (Promega) according to the manufacturer's protocol using random primers. cDNA levels were measured by real-time polymerase chain reaction (PCR) using the ABI Prism 7700 Sequence Detection System (Applied Biosystems, Foster City, Calif), according to the manufacturer's instructions. PCR mastermix from Eurogentec was used. Primers and probes were obtained from Biosource (Nivelles, Belgium). The probes were labeled with 3Ј-BHQ1 and 5Ј-FAM or 5Ј-TET. The mRNA levels were normalized to mRNA levels of different housekeeping genes (ie, cyclophilin, HPRT, and GAPDH). Primers and probes used for this study are summarized in Table 1 . The level of mRNA expression for each gene of interest was calculated using the C t values. C t values are defined as the number of PCR cycles at which the fluorescent signal generated during the PCR reaches a fixed threshold. For each sample, the C t for the target gene and for the housekeeping gene were determined to calculate ⌬C t (C t,target gene Ϫ C t,housekeeping gene ). Subsequently, ⌬⌬C t was determined by subtracting the ⌬C t of the test group from the ⌬C t of the control group, and the relative gene expression levels were calculated from 2 Ϫ⌬⌬Ct , according to the manufacturer's instructions (Applied Biosystems). In each case, we checked that the ⌬⌬C t method was valid by showing that ⌬C t is constant over a range of cDNA solutions. For some signals (acyl-CoA synthase [Acas1], steroyl-CoA desaturase [Scd1; LocusLink number 20249], peroxisomal bifunctional enzyme [Ehhadh; Lo-cusLink number 108132], and thiolase [Acaa1; LocusLink number 113868]), we performed Northern blot analysis as described. 15 Liver lipids were measured as described. 15 
VLDL-Triglyceride and Apolipoprotein B Production
After overnight fasting to prevent chylomicron production, mice were injected via the tail vein with 0.1 mL phosphate buffered saline (PBS) containing 100 Ci Tran 35 S-label (ICN), a mixture of 35 S-labeled methionine and cysteine. After 30 minutes, they were treated with Triton WR-1339 (500 mg/kg intravenous), which virtually completely inhibits VLDL clearance by blocking LPL-mediated lipolysis. The accumulation of VLDL-triglyceride in plasma and the incorporation of radiolabeled amino acids into newly synthesized apolipoprotein B over 90 minutes were measured essentially as described. 16 
Fecal Excretion of Bile Acids and Neutral Sterols
APOE*3-Leiden and cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice were housed at 3 mice per cage. Feces produced during 3 subsequent periods were separated from the wood shavings by sieving. Aliquots of lyophilized feces were used for determination of neutral and acidic sterol content by gas-liquid-chromatography procedures described. 15 
Lipolysis
Postheparin plasma from fasted mice (overnight) was collected from the tail vein at 20 minutes after intraperitoneal injection of heparin (1.0 U/g body weight). Postheparin plasma triacylglycerol hydrolase activity was determined in the presence or absence of 1 mol/L NaCl to estimate the lipoprotein lipase (LPL) activity, which was calculated as the portion of total triacylglycerol hydrolase activity inhibited by 1 mol/L NaCl. 15
Western Blotting
Western blot analysis was performed as previously described. 17 Liver homogenates (50 g protein) were electrophoresed on a sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE), and proteins were blotted onto nitrocellulose as described. 17 Blots were developed with an anti-sterol regulatory element binding protein-1 (SREBP-1) primary antibody and horseradish peroxidase-conjugated secondary immunoglobulin. All antibodies were diluted in 20 mmol/L Tris (pH 7.4), 55 mmol/L NaCl, 0.1% (v/v) Tween-20, and 5% (wt/vol) bovine serum albumin and were used at a final concentration of 0.2 g/mL. The Super Signal West Dura Extended Duration Substrate (Pierce, St Augustin, Germany) and the luminescent image workstation (Roche Diagnostics) were used for SREBP-1 visualization. After incubation for 5 minutes in a shaking water bath at 37°C, the reaction was terminated by adding 4 mL of chloroform/methanol (2:1 vol/vol); 20 L of [ 3 H]triolein (Ϸ3000 dpm) (Amersham) in toluene was added to monitor the extraction efficiency. After phase separation by addition of 750 L of dH 2 O, lipids were extracted, dried under nitrogen, dissolved in chloroform, and spotted onto a channeled 20ϫ20-cm Silica gel TLC plate (LK5D 150 A; Whatman). The lipids were separated by running the TLC plate in chloroform/methanol (98:2 vol/vol, halfway), followed by chloroform/hexane (35:65 vol/vol). The radioactive triolein bands were visualized by autoradiography and scraped off for scintillation counting in 4 mL of Ultima Gold (Packard).
Diacylglycerol Acyltransferase Activity Assay
Vitamin Analysis
Liver samples were saponified during 30 minutes under reflux conditions using ethanolic KOH containing glycerol, Na 2 S, and 2% sodium ascorbate. After cooling to room temperature, vitamins were extracted by isopropylether. The extract was washed once using 5% KOH, followed by 2 washes with water. After dissolving the vitamins in isopropylether, the ether was dried under a gentle stream of nitrogen and the residue dissolved in heptane. Subsequently, the samples were analyzed for tocopherols (ie, vitamin E) and retinols (ie, vitamin A) using straight-phase HPLC with fluorescence detection.
Statistics
Data were analyzed statistically using Student unpaired t test, with the level of significance selected to be PϽ0.05. Values are expressed as meansϮSD.
Results
Effect of cyp7a1 Deficiency on Fecal Sterols and Plasma Lipid Levels
To evaluate the effect of cyp7a1 deficiency on regular and elevated plasma lipid levels, female APOE*3-Leiden and cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice were fed a normal chow diet and a sucrose-rich diet, respectively. On chow diet, the absence of cyp7a1 in APOE*3-Leiden mice resulted in a decrease in bile acid biosynthesis as reflected by a reduced fecal bile acid excretion (Ϫ73%) ( Figure 1A) . As a consequence, the fecal neutral sterol output was 2-fold increased in the cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice ( Figure 1B) . The basal levels of fecal bile acid and neutral sterol output on sucroserich diet were significantly lower compared with chow diet (Ϫ37% and Ϫ57%, respectively). However, the relative effect on fecal bile acid and neutral sterol output was similar ( Figure 1 ).
The differences in bile acid biosynthesis did not result in an effect on plasma cholesterol levels on an APOE*3-Leiden background as well as on a wild-type background on chow diet (Table 2 ). However, triglyceride levels were 41% and 29% decreased (mainly confined to the VLDL fraction) in the cyp7a1 Ϫ/Ϫ .APOE*3-Leiden and cyp7a1 Ϫ/Ϫ mice, respectively, as compared with their control littermates. On the sucroserich diet, basal cholesterol levels in the cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice increased from 2.6Ϯ0.8 mmol/L to 4.4Ϯ1.1 mmol/L (PϽ0.05) and from 1.6Ϯ0.3 mmol/L to 2.6Ϯ0.6 mmol/L (PϽ0.05) in the cyp7a1 Ϫ/Ϫ mice, whereas triglyceride levels did not change. The plasma lipid-inducing effects of the sucrose-rich diet in APOE*3-Leiden mice is lower as compared with our previous observations, 12 which is probably related to continued back-crossing of the mice from the original CBA/J background to the C57Bl/6J background. On this diet, cyp7a1 deficiency on an APOE*3-Leiden and wild-type background had a similar decreasing effect on plasma triglyceride levels (38% and 38%, respectively) as on chow diet and had no effect on cholesterol levels ( Table 2) .
Effect of cyp7a1 Deficiency on Plasma Lipolytic Activity, Ketone Bodies and VLDL Production
The decreasing effect of cyp7a1 deficiency on triglyceride levels could be caused by altered LPL activity, ␤-oxidation of fatty acids, or VLDL production. To further investigate the mechanism behind the reduced plasma triglyceride levels in cyp7a1 deficiency, we measured postheparin LPL activity as a measure of peripheral lipolysis. It appeared that the triacylglycerol hydrolase activity of LPL did not differ between female APOE*3-Leiden and cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice (fatty acid production rate 4.0Ϯ2.0 mol/mL per hour versus 2.4Ϯ1.9 mol/mL per hour, respectively; nϭ8 per group; PϽ0.05). Rather, a trend was observed toward decreased LPL levels in cyp7a1 Ϫ/Ϫ mice. In addition, no changes were observed in plasma levels of ketone bodies (␤-hydroxybutyrate) as markers of oxidation of fatty acids (1.79Ϯ0.53 mmol/L versus 1.79Ϯ0.33 mmol/L, respectively; nϭ8 per group), although the expression of various genes involved in hepatic ␤-oxidation, eg, acyl-CoA oxidase (acox1), acyl-CoA synthase (acas1), peroxisomal bifunctional enzyme (ehhadh), and thiolase (acca1), were increased (Table 3 ). In contrast, hepatic VLDL-apolipoprotein B and VLDL-triglyceride production rates were reduced in the cyp7a1 Ϫ/Ϫ .APOE*3-Leiden as compared with the APOE*3-Leiden mice (34% and 35%, respectively) (PϽ0.05) ( Figure  2 ). The lipid composition of the nascent VLDL particles was not changed (see insert in Figure 2B ), indicating that cyp7a1 deficiency results in a decreased hepatic VLDL particle production rate. Although the microsomal triglyceride transfer protein (mttp), apolipoprotein B (apob), and apolipoprotein B mRNA-editing complex-1 (apobec-1) play a critical role in the assembly and secretion of VLDL in the liver, the hepatic expression levels of these genes were not significantly different between cyp7a1 Ϫ/Ϫ .APOE*3-Leiden and APOE*3-Leiden mice ( Table 3) .
Effect of cyp7a1 Deficiency on Hepatic Lipogenesis, Lipid Content, and Vitamin Levels
To investigate the effect of the lack of cyp7a1 on hepatic triglyceride synthesis, mRNA and protein levels of the transcription factor SREBP-1 (srebf1), which regulates lipo- 
APOE*3-Leiden (E3L) and cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice were fed a sucrose-rich diet. mRNA was isolated from the livers of the mice and measured by real-time PCR as described in the Methods section. Values (percentage of APOE*3-Leiden) shown are meanϮSD of 5 mice per group. Cyclophilin A was used as a control, but similar results were obtained using different housekeeping genes. Significant differences between APOE*3-Leiden and cyp7a1 Ϫ/Ϫ .APOE*3-Leiden are indicated by an asterisk. *PϽ0.05;
†PϽ0.001.
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Reduced VLDL Production in Cyp7a1 ؊/؊ .APOE*3-Leiden Mice genic genes, were measured. Also, the mRNA expression levels of enzymes involved in fatty acid synthesis, ie, fatty acid synthase (fasn), acyl-CoA carboxylase (acac) and steroyl-CoA desaturase (scd1) were measured. The srebf1 mRNA level was 31% lower in the cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice, which was accompanied by a significant (PϽ0.05; nϭ4 per group) reduction in the amount of mature (100%Ϯ27% versus 35%Ϯ28%) and precursor (100%Ϯ47% versus 62%Ϯ54%) form of SREBP-1 and a lower expression of the lipogenesis genes acac and fasn ( Table 3) .
As a consequence of a decreased bile acid production and a reduction in VLDL secretion, hepatic free cholesterol, esterified cholesterol, and triglyceride levels were significantly increased (1.3-, 2.8-, and 2.5-fold, respectively) in the cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice, whereas hepatic phospholipid levels were significantly decreased by Ϫ28% ( Table 4 ). The increase in hepatic cholesterol levels was related to a 49% reduction in the expression of the low-density lipoprotein receptor (ldlr) ( Table 3) .
To investigate whether the changes in the hepatic content in phospholipids and triglycerides were caused by a change in the enzyme activity of DGAT, we performed a DGAT activity assay with microsomes isolated from the livers of the APOE*3-Leiden (nϭ6) and cyp7a1 Ϫ/Ϫ .APOE*3-Leiden (nϭ7) mice fed the sucrose-rich diet. We found no significant difference between these groups with respect to the activity of this enzyme (10.0Ϯ1.7 nmol/min per mg protein versus 9.0Ϯ1.4 nmol/min per mg protein, respectively).
Anti-oxidative vitamins play a role in determining the hepatic content of reactive oxygen species, which can be involved in the degradation of apolipoprotein B. Therefore, we measured the amount of vitamin A and E in the liver. The data of Table 4 show that cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice contain greatly reduced levels of the fat-soluble vitamins A and E in the liver as compared with their APOE*3-Leiden littermates.
Discussion
This study showed that the absence of cyp7a1 in female APOE*3-Leiden mice results in a decrease in plasma triglyceride levels as a consequence of a lower VLDL production.
Cyp7a1 knockout mice on an APOE*3-Leiden background as well as on a wild-type background of both sexes did not have different plasma cholesterol levels as compared with their control littermates. Although this is in agreement with a previous report, 11 a hypercholesterolemic cyp7a1 Ϫ/Ϫ colony has recently also been described. 18 Similarly, conflicting effects on plasma triglyceride levels have been reported 11, 18 in mice lacking cyp7a1. No significant difference in plasma triglyceride levels was found in the cyp7a1 Ϫ/Ϫ mice with normal cholesterol levels, whereas the females of the hypercholesterolemic cyp7a1 Ϫ/Ϫ colony exhibited lower plasma triglyceride levels. 18 The differences in phenotype may be because of sex, genetic background, diet, or other environmental factors. In our hands, cyp7a1 deficiency on a human-like lipoprotein profile and on a wildtype background consistently showed decreased plasma triglyceride levels in only the female mice similarly as previously described. 18 The absence of an effect in male mice can possibly be explained by the lower level in VLDL-triglyceride produc- In liver homogenates of APOE*3-Leiden and cyp7a Ϫ/Ϫ .APOE*3-Leiden mice fed a sucrose-rich diet, free cholesterol (FC), cholesteryl esters (CE), triglycerides (TG), and phospholipids (PL) were determined after lipid extraction as described in the Methods section. Data are meanϮSD (nϭ4 per group). Hepatic vitamin levels were measured as described in the Methods section. Values shown are meansϮSD of 5 mice per group and are expressed as ng/g TG. Values between brackets are percentages of the APOE*3-Leiden values. A significant difference is indicated by an asterisk. *PϽ0.05; †PϽ0.005. tion in males as compared with females as a result of the difference in hormone level. 19 We have shown that the lower level of plasma triglycerides in the female cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice is caused by inhibition of VLDL particle production. It has been known for many years that there is a link between bile acid metabolism, especially related to cyp7a1 expression, and hepatic VLDL production. Treatment with the bile acid sequestrant cholestyramine, which induces bile acid biosynthesis, leads to an increase in VLDL triglyceride and VLDL cholesterol production. This increase is seen in healthy individuals 4 and in patients with various types of hyperlipidemia, 9, 20 and predominantly in patients with hypertriglyceridemia. 8, 9 In animals, this relation between bile acid biosynthesis and plasma triglyceride levels has also been detected. Disruption of the enzyme sterol 27hydroxylase in mice leads to a 5-fold increase in cyp7a1 activity and a concomitant 2-fold increase in hepatic and plasma triglyceride levels. 7 Furthermore, cyp7a1 transgenic mice have an increased production and secretion of apolipoprotein B-containing lipoproteins. 6 We did not observe an effect of cyp7a1 deficiency on plasma cholesterol levels. Apparently, the reduced influx of cholesterol into plasma resulting from a reduced VLDL production and reduced intestinal neutral sterol cholesterol absorption is counterbalanced by a decreased hepatic cholesterol clearance. Indeed, the ldlr expression was reduced, probably as a result of downregulation, as induced by increased hepatic cholesterol levels.
The hepatic synthesis of VLDL particles requires many (in)dependent processes like: (1) the production of constituting lipids; (2) the synthesis and secretion of apolipoprotein B and apolipoprotein E; (3) the transfer of lipid by MTP to apolipoprotein B; and (4) association of the resulting precursor particle with bulk lipid to form mature VLDL. 21 We did not find an effect of cyp7a1 deficiency on mttp mRNA levels. Because MTP protein and activity are tightly regulated by mttp mRNA levels, 22 hepatic MTP activity is thus likely to be unaltered. In contrast, cyp7a1overexpressing animals were reported to have increased mttp expression, 6 which, however, may result from an unphysiologically high cyp7a1 expression.
Studies with hepatoma cells overexpressing cyp7a1 showed that as a result of increased mature SREBP-1, there was a coordinate induction of de novo lipogenesis and assembly and secretion of VLDL. 23 We found a decrease in srebf1, mRNA, and SREBP-1 protein leading to suppression of genes involved in de novo lipogenesis, ie, fas and acc1, which may contribute to reduced VLDL secretion. Despite the decreased de novo lipogenesis, hepatic triglyceride levels were increased. These data indicate that a decreased de novo lipogenesis does not automatically lead to smaller triglyceride content in the liver, which is in line with the absence of an effect on hepatic triglyceride levels in srebf1-deficient mice. 24 Alternatively, the decrease in lipogenesis can also be the consequence of the high level of triglycerides in the liver. In contrast, cyp7a1 Ϫ/Ϫ mice on a wild-type background have no difference in hepatic triglyceride content and have decreased fatty acid synthesis. 18 Differences between triglyceride and fatty acid metabolism in the cyp7a1 Ϫ/Ϫ mice and cyp7a1 Ϫ/Ϫ . APOE*3-Leiden mice may be explained by the presence of the APOE*3-Leiden and APOC1 gene.
Because the increased triglyceride content cannot be explained by the effect on de novo lipogenesis, we measured DGAT. DGAT is another important enzyme in determining the triglyceride content in the liver, producing triglycerides from diacylglycerides and acyl-CoAs. Because we found no alteration in the enzyme activity of DGAT, we can exclude the possibility that this enzyme is involved in the accumulation of triglycerides in the liver or the decrease in VLDL production. The increase in hepatic triglyceride content can also be a consequence of the extreme blockade in the output of fatty acids in the form of phospholipids via the bile, together with a decrease in VLDL production. Biliary bile acid excretion is an important determinant of biliary phospholipids and cholesterol excretion. 25 Our data show that affecting bile acid metabolism has a major impact on hepatic fatty acid metabolism, not only on genes involved in de novo lipogenesis but also on genes involved in hepatic oxidation of fatty acids. The general effects of cyp7a1 deficiency in this animal model, except from the lack of effect on LPL, closely resemble the effects of treating mice with PPAR␣agonists (ie, fibrates). It has been shown that fibrates decrease triglyceride levels, increase expression of genes involved in ␤-oxidation, and reduce VLDL production and the expression of genes involved in fatty acid synthesis. 26 We also reported that after treatment of mice with ciprofibrate, bile acid synthesis is suppressed via PPAR␣-mediated downregulation of cyp7a1 and sterol 27-hydroxylase. 27 Therefore, we cannot exclude that PPAR␣ plays a role in the effects observed in the cyp7a1deficient mouse. In addition, bile acids have been shown to interfere with transactivation by PPAR␣, at least in part by impairing the recruitment of transcriptional co-activators. 28 The decreased bile acid pool in the cyp7a1 knockout mice may explain the changes in PPAR␣-regulated genes involved in ␤-oxidation eg, acox1, acac1, and ehhadh. The increase in acox1 has also been found by others. 18 Despite the increase in expression levels of genes involved in ␤-oxidation, which may have contributed to the differences in fatty acid and triglyceride metabolism in the cyp7a1 Ϫ/Ϫ .APOE*3-Leiden, the concentration of plasma ketone bodies remained unaltered.
We showed that cyp7a1 deficiency affected the VLDL secretion rate. The nascent VLDL composition was not changed, although a trend was observed toward a higher cholesteryl ester/triglyceride ratio within the particle core. The constituting core lipids in VLDL (ie, cholesteryl esters and triglycerides) were available in sufficient amounts in the liver of the female cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice, but it can be possible that deposition of these lipids in the liver is not present in the secretory route where proteins are located, which are involved in the packaging of lipids into VLDL particles. Moreover, we found that the amount of hepatic phospholipids was decreased. It has been reported that the hepatocellular phospholipid availability is a determinant for the regulation of VLDL assembly. 29 -32 Furthermore, intracellular proteolysis of apolipoprotein B, resulting in a diminished assembly of VLDL particles, may be increased in female cyp7a1 Ϫ/Ϫ .APOE*3-Leiden mice. We and others 11 showed that cyp7a1 deficiency in mice results in a low level of anti-oxidative vitamins caused by a reduction in the intestinal uptake. 11 This consequently leads to an excess in intracellular reactive oxygen species. Recently, it has been shown that a novel pathway for destruction of newly synthesized apolipoprotein B is induced by intracellular reactive oxygen species and PI3-kinases. 33, 34 This may be a possible explanation for the difference in VLDL production in the knockout mice as compared with their littermates.
In conclusion, our data show that female cyp7a1 Ϫ/Ϫ . APOE*3-Leiden mice have a decreased VLDL production as a consequence of a strongly reduced bile acid biosynthesis, leading to a decrease in plasma triglyceride levels. These data indicate a major impact of physiological cyp7a1 expression on VLDL production and further underscore the link between bile acid biosynthesis and triglyceride levels.
